List of Excipients in API insulin glargine and lixisenatide
✉ Email this page to a colleague
Detailed excipient profiles for insulin glargine and lixisenatide
Excipient focus: GLYCERIN
insulin glargine and lixisenatide drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
>Company | >Ingredient | >NDC |
insulin glargine and lixisenatide drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
insulin glargine and lixisenatide drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
>Company | >Ingredient | >NDC |
insulin glargine and lixisenatide drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METACRESOL
insulin glargine and lixisenatide drug variants containing METACRESOL
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
>Company | >Ingredient | >NDC |
insulin glargine and lixisenatide drug variants not containing METACRESOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
insulin glargine and lixisenatide drug variants containing METHIONINE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
>Company | >Ingredient | >NDC |
insulin glargine and lixisenatide drug variants not containing METHIONINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
insulin glargine and lixisenatide drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
>Company | >Ingredient | >NDC |
insulin glargine and lixisenatide drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
insulin glargine and lixisenatide drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
>Company | >Ingredient | >NDC |
insulin glargine and lixisenatide drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ZINC CHLORIDE
insulin glargine and lixisenatide drug variants containing ZINC CHLORIDE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
>Company | >Ingredient | >NDC |
insulin glargine and lixisenatide drug variants not containing ZINC CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.